PDF herunterladen
CC BY 4.0 · Rev Bras Ginecol Obstet 2023; 45(01): 011-020
DOI: 10.1055/s-0042-1759633
Original Article | Artigo Original
High Risk Prenancy

Maternal Near Miss in Patients with Systemic Lupus Erythematosus

Near miss materno em pacientes com lupus eritematoso sistêmico
Arlley Cleverson Belo da Silva 
1   Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil
,
Sue Yazaki Sun 
1   Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil
,
Felipe Favorette Campanharo 
1   Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil
,
Letícia Tiemi Morooka 
1   Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil
,
José Guilherme Cecatti 
2   Universidade Estadual de Campinas, Campinas, SP, Brazil
,
Rosiane Mattar 
1   Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil
› Institutsangaben
› Weitere Informationen
   Lizenzen und Reprints

Abstract

Objective Systemic lupus erythematosus (SLE) may cause irreversible organ damage. Pregnancy with SLE may have severe life-threatening risks. The present study aimed to determine the prevalence of severe maternal morbidity (SMM) in patients with SLE and analyze the parameters that contributed to cases of greater severity.

Methods This is a cross-sectional retrospective study from analysis of data retrieved from medical records of pregnant women with SLE treated at a University Hospital in Brazil. The pregnant women were divided in a control group without complications, a group with potentially life-threatening conditions (PLTC), and a group with maternal near miss (MNM).

Results The maternal near miss rate was 112.9 per 1,000 live births. The majority of PLTC (83.9%) and MNM (92.9%) cases had preterm deliveries with statistically significant increased risk compared with the control group (p = 0.0042; odds ratio [OR]: 12.05; 95% confidence interval [CI]: 1.5–96.6 for the MNM group and p = 0.0001; OR: 4.84; 95%CI: 2.2–10.8 for the PLTC group). Severe maternal morbidity increases the risk of longer hospitalization (p < 0.0001; OR: 18.8; 95%CI: 7.0–50.6 and p < 0.0001; OR: 158.17; 95%CI: 17.6–1424,2 for the PLTC and MNM groups, respectively), newborns with low birthweight (p = 0.0006; OR: 3.67; 95%CI: 1.7–7.9 and p = 0.0009; OR: 17.68; 95%CI: 2–153.6) for the PLTC and MNM groups, respectively] as well as renal diseases (PLTC [8.9%; 33/56; p = 0.0069] and MNM [78.6%; 11/14; p = 0.0026]). Maternal near miss cases presented increased risk for neonatal death (p = 0.0128; OR: 38.4; 95%CI: 3.3–440.3]), and stillbirth and miscarriage (p = 0.0011; OR: 7.68; 95%CI: 2.2–26.3]).

Conclusion Systemic lupus erythematosus was significantly associated with severe maternal morbidity, longer hospitalizations, and increased risk of poor obstetric and neonatal outcomes.

Resumo

Objetivo: Lúpus eritematoso sistêmico (LES) pode causar danos irreversíveis aos órgãos. A gravidez com LES pode ter riscos para condições ameaçadoras à vida. O presente estudo teve como objetivo determinar a prevalência de MMG em pacientes com LES e analisar os parâmetros que contribuíram para os casos de maior gravidade.

Métodos Trata-se de um estudo transversal retrospectivo a partir da análise de dados obtidos de prontuários de gestantes com LES atendidas em um Hospital Universitário no Brasil. As gestantes foram divididas em grupo controle sem intercorrências, grupo com condições potencialmente ameaçadoras a vida (CPAV) e grupo com near miss materno (NMM).

Resultados A taxa de NMM foi de 112,9 por 1.000 nascidos vivos. A maioria dos casos de CPAV (83,9%) e NMM (92,9%) teve partos prematuros com risco aumentado estatisticamente significativo em comparação com o grupo controle (p = 0,0042; odds ratio [OR]: 12,05; intervalo de confiança [IC]: 1,5–96,6 para o grupo NMM e p = 0,0001; OR: 4,84; IC95%: 2,2–10,8 para o grupo CPAV). MMG aumenta o risco de maior tempo de internação (p < 0,0001; OR: 18,8; IC95%: 7,0–50,6 e p < 0,0001; OR: 158,17; IC95%: 17,6–1424,2 para os grupos CPAV e NMM, respectivamente), recém-nascidos com baixo peso (p = 0,0006; OR: 3,67; IC95%: 1,7–7,9 e p = 0,0009; OR: 17,68; IC95%: 2–153,6 para os grupos CPAV e NMM, respectivamente), bem como doenças renais (CPAV: 58,9%; 33/56; p = 0,0069 e NMM: 78,6%; 11/14; p = 0,0026)]. Os casos de NMM apresentaram risco aumentado para óbito neonatal (p = 0,0128; OR: 38,4; IC95%: 3,3–440,3), natimorto e aborto espontâneo (p = 0,0011; OR: 7,68; IC95%: 2,2–26,3).

Conclusão Lúpus eritematoso sistêmico foi significativamente associado à morbidade materna grave, internações mais longas e risco aumentado de desfechos obstétricos e neonatais ruins.

Keywords

maternal near miss - severe maternal morbidity - systemic lupus erythematosus - high risk pregnancy - potentially life-threatening conditions

Palavras-chave

near miss materno - morbidade materna grave - lúpus eritematoso sistêmico - gravidez de alto risco - condições potencialmente ameaçadora à vida

Contributors

All authors participated in the concept and design of the study, in the analysis and interpretation of data, in the draft or revision of the manuscript, and they have approved the manuscript as submitted. All authors are responsible for the reported research.




Publikationsverlauf

Eingereicht: 24. Mai 2022

Angenommen: 25. August 2022

Artikel online veröffentlicht:
06. März 2023

© 2023. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • References

  • 1 Borba EF, Latorre LC, Brenol JC. et al. [Consensus of systemic lupus erythematosus]. Rev Bras Reumatol 2008; 48 (04) 196-207
    CrossrefPubMedSuche in Google Scholar
  • 2 Uramoto KM, Michet Jr CJ, Thumboo J, Sunku J, O'Fallon WM, Gabriel SE. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum 1999; 42 (01) 46-50 . Doi: 10.1002/1529-0131(199901)42:1<46:AID-ANR6>3.0.CO;2-2
    CrossrefPubMedSuche in Google Scholar
  • 3 Elfving P, Puolakka K, Kautiainen H, Virta LJ, Pohjolainen T, Kaipiainen-Seppänen O. Mortality and causes of death among incident cases of systemic lupus erythematosus in Finland 2000-2008. Lupus 2014; 23 (13) 1430-1434
    CrossrefPubMedSuche in Google Scholar
  • 4 Mirabelli G, Cannarile F, Bruni C, Vagelli R, De Luca R, Carli L. One year in review 2015: systemic lupus erythematosus. Clin Exp Rheumatol 2015; 33 (03) 414-425
    PubMedSuche in Google Scholar
  • 5 Pamuk ON, Balci MA, Donmez S, Tsokos GC. The incidence and prevalence of systemic lupus erythematosus in Thrace, 2003-2014: A 12-year epidemiological study. Lupus 2016; 25 (01) 102-109
    CrossrefPubMedSuche in Google Scholar
  • 6 de Jesus GR, Mendoza-Pinto C, de Jesus NR, Dos Santos FC, Klumb EM, Carrasco MC. et al. Understanding and managing pregnancy in patients with lupus. Autoimmune Dis 2015; 2015: 943490
    CrossrefPubMedSuche in Google Scholar
  • 7 Yang MJ, Chen CY, Chang WH, Tseng JY, Yeh CC. Pregnancy outcome of systemic lupus erythematosus in relation to lupus activity before and during pregnancy. J Chin Med Assoc 2015; 78 (04) 235-240
    CrossrefPubMedSuche in Google Scholar
  • 8 Kwok LW, Tam LS, Zhu T, Leung YY, Li E. Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythematosus. Lupus 2011; 20 (08) 829-836
    CrossrefPubMedSuche in Google Scholar
  • 9 Say L, Souza JP, Pattinson RC. WHO working group on Maternal Mortality and Morbidity classifications. Maternal near miss–towards a standard tool for monitoring quality of maternal health care. Best Pract Res Clin Obstet Gynaecol 2009; 23 (03) 287-296
    CrossrefPubMedSuche in Google Scholar
  • 10 Cecatti JG, Costa ML, Haddad SM, Parpinelli MA, Souza JP, Sousa MH. et al; Brazilian Network for Surveillance of Severe Maternal Morbidity study Group. Network for Surveillance of Severe Maternal Morbidity: a powerful national collaboration generating data on maternal health outcomes and care. BJOG 2016; 123 (06) 946-953
    CrossrefPubMedSuche in Google Scholar
  • 11 Oliveira LC, Costa AA. Fetal and neonatal deaths among cases of maternal near miss. Rev Assoc Med Bras 2013; 59 (05) 487-494
    CrossrefPubMedSuche in Google Scholar
  • 12 Morse ML, Fonseca SC, Gottgtroy CL, Waldmann CS, Gueller E. Severe maternal morbidity and near misses in a regional reference hospital. Rev Bras Epidemiol 2011; 14 (02) 310-322 . Doi: 10.1590/s1415-790 × 2011000200012
    CrossrefPubMedSuche in Google Scholar
  • 13 De Mucio B, Abalos E, Cuesta C, Carroli G, Serruya S, Giordano D. et al; Latin American Near Miss Group (LANe-MG). Maternal near miss and predictive ability of potentially life-threatening conditions at selected maternity hospitals in Latin America. Reprod Health 2016; 13 (01) 134
    CrossrefPubMedSuche in Google Scholar
  • 14 Cecatti JG, Souza JP, Parpinelli MA, Camargo RS, Pacagnella RC, Silveira C. et al; Brazilian Network for Surveillance of Severe Maternal Morbidity. Brazilian network for the surveillance of maternal potentially life threatening morbidity and maternal near-miss and a multidimensional evaluation of their long term consequences. Reprod Health 2009; 6: 15
    CrossrefPubMedSuche in Google Scholar
  • 15 Cecatti JG, Souza JP, Oliveira Neto AF, Parpinelli MA, Sousa MH, Say L. et al. Pre-validation of the WHO organ dysfunction based criteria for identification of maternal near miss. Reprod Health 2011; 8: 22
    CrossrefPubMedSuche in Google Scholar
  • 16 Brown HL, Small M, Taylor YJ, Chireau M, Howard DL. Near miss maternal mortality in a multiethnic population. Ann Epidemiol 2011; 21 (02) 73-77
    CrossrefPubMedSuche in Google Scholar
  • 17 Kalisa R, Rulisa S, van den Akker T, van Roosmalen J. Maternal Near Miss and quality of care in a rural Rwandan hospital. BMC Pregnancy Childbirth 2016; 16 (01) 324
    CrossrefPubMedSuche in Google Scholar
  • 18 Peart E, Clowse ME. Systemic lupus erythematosus and pregnancy outcomes: an update and review of the literature. Curr Opin Rheumatol 2014; 26 (02) 118-123
    CrossrefPubMedSuche in Google Scholar
  • 19 Smyth A, Oliveira GH, Lahr BD, Bailey KR, Norby SM, Garovic VD. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol 2010; 5 (11) 2060-2068
    CrossrefPubMedSuche in Google Scholar
  • 20 Lateef A, Petri M. Systemic lupus erythematosus and pregnancy. Rheum Dis Clin North Am 2017; 43 (02) 215-226
    CrossrefPubMedSuche in Google Scholar
  • 21 Mok CC, Wong RW. Pregnancy in systemic lupus erythematosus. Postgrad Med J 2001; 77 (905) 157-165
    CrossrefPubMedSuche in Google Scholar
  • 22 Murata T, Kyozuka H, Fukuda T, Yasuda S, Yamaguchi A, Sato A. et al; Japan Environment and Children's Study Group. Risk of adverse obstetric outcomes in Japanese women with systemic lupus erythematosus: The Japan Environment and Children's Study. PLoS One 2020; 15 (05) e0233883
    CrossrefPubMedSuche in Google Scholar
  • 23 He WR, Wei H. Maternal and fetal complications associated with systemic lupus erythematosus: An updated meta-analysis of the most recent studies (2017-2019). Medicine (Baltimore) 2020; 99 (16) e19797
    CrossrefPubMedSuche in Google Scholar
  • 24 World Health Organization. Evaluating the quality of care for severe pregnancy complications: the WHO near-miss approach for maternal health. Geneva: WHO; 2011
    Suche in Google Scholar
  • 25 Lima F, Buchanan NM, Khamashta MA, Kerslake S, Hughes GR. Obstetric outcome in systemic lupus erythematosus. Semin Arthritis Rheum 1995; 25 (03) 184-192
    CrossrefPubMedSuche in Google Scholar
  • 26 Yang H, Liu H, Xu D, Zhao L, Wang Q, Leng X. et al. Pregnancy-related systemic lupus erythematosus: clinical features, outcome and risk factors of disease flares–a case control study. PLoS One 2014; 9 (08) e104375
    CrossrefPubMedSuche in Google Scholar
  • 27 Zamani B, Shayestehpour M, Esfahanian F, Akbari H. The study of factors associated with pregnancy outcomes in patients with systemic lupus erythematosus. BMC Res Notes 2020; 13 (01) 185
    CrossrefPubMedSuche in Google Scholar